霍华德 A. 霍华德 医学博士"跳过"伯里斯三世:一个瘤学先驱对患者,进步和目的进行了反思
The American journal of managed care
|February 23, 2026
概括
这篇反思详细介绍了萨拉·坎农研究所第一阶段药物开发计划创始人的职业生涯. 它强调了早期临床试验和药物发现的关键经验.
科学领域:
- 在瘤学瘤学.
- 临床药理学 临床药理学
- 药物开发 药物开发
背景情况:
- 早期临床试验的场景已经发生了显著的变化.
- 开创药物开发计划需要战略愿景和力.
- 学术和社区研究机构在推进癌症治疗方面发挥着至关重要的作用.
研究的目的:
- 提供关于建立和发展第一阶段药物开发计划的个人反思.
- 分享从致力于早期瘤学研究的职业生涯中获得的见解.
- 为患者提供新型癌症药物的挑战和成功提供历史视角.
主要方法:
- 回顾职业生涯的回顾.
- 个人叙事和反思.
- 对历史程序开发里程碑的分析.
主要成果:
- 一个领先的第一阶段药物开发计划的成功建立和持续增长.
- 对多种新瘤治疗方法的进步做出贡献.
- 为早期临床试验执行制定一个强大的框架.
结论:
- 建立第一阶段计划的旅程是复杂的,但有回报.
- 对创新的持续承诺对于瘤药物开发的进展至关重要.
- 导师和合作是临床研究中长期成功的关键.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Patient-centered Care
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


